When was CBPartners founded?

CBPartners was founded in 2012.

Where is CBPartners located?

CBPartners is headquartered in New York City, United States.

How many employees does CBPartners have?

As of May 31, 2026, the latest employee count at CBPartners is 13.

Is CBPartners a funded company?

CBPartners is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does CBPartners rank among its competitors?

CBPartners ranks 367th amongst 1349 active competitors, of which 26 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of CBPartners?

CBPartners' top competitors include Indegene, IntegriChain and Prescient Healthcare Group. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

CBPartners - 2026 Company Profile & Competitors

CBPartners is an acquired company based in New York City (United States), founded in 2012. It operates as a Provider of biopharma consulting services. The company has 1349 active competitors, including 26 funded and 149 that have exited. Its top competitors include companies like Indegene, IntegriChain and Prescient Healthcare Group.

Company Details

Website: cbpartners.com
Social

Key Metrics

Founded Year

2012

Location

New York City, United States

Stage

Acquired

Ranked

367^th among 1349 active competitors

Employee Count

13 as on May 31, 2026

Similar Companies

Indegene & 1608 more

Exit Details

Acquired by Trinity (Oct 07, 2021)

View CBPartners' full profile

CBPartners got acquired by Trinity on Oct 07, 2021.

Click here to take a look at CBPartners's acquisition in detail

CBPartners has not raised any funding rounds yet.

CBPartners' employee count trend

CBPartners has 13 employees as of May 26. Here is CBPartners's employee count trend over the years:

Uncover CBPartners' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CBPartners include Indegene, IntegriChain and Prescient Healthcare Group. Here is the list of Top 10 competitors of CBPartners, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Indegene 1998, Princeton (United States), Public	Suite solutions for payers and healthcare providers	$255M	Syneos Health, Cadawninvestmentcompany & 17 others	78/100
2nd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	63/100
3rd	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Bridgepoint Group, Intertrust & 8 others	60/100
4th	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	59/100
5th	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
6th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	57/100
7th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
8th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	55/100
9th	Spectrum Pharmatech Consultants 1995, Thane (India), Unfunded	Provider of diversified consulting services for biopharma sector	-	-	49/100
10th	Avalon Bio Ventures 1983, San Diego (United States), Unfunded	Venture capital firm and startup accelerator focused on life science companies	-	-	48/100
367th	CBPartners 2012, New York City (United States), Acquired	Provider of biopharma consulting services	-	-	23/100